NFKB1 and diabetic kidney disease: Previous studies have shown that activation of the PPAR signaling pathway can reduce the production of inflammatory cytokines by downregulating pro-inflammatory pathways such as NF-κB, thereby playing a protective role in chronic inflammatory diseases such as DKD (39, 40).